Berti, L., Irmler, M., Zdichavsky, M., Meile, T., Böhm, A., Stefan, N., . . . Staiger, H. (2015). Fibroblast growth factor 21 is elevated in metabolically unhealthy obesity and affects lipid deposition, adipogenesis, and adipokine secretion of human abdominal subcutaneous adipocytes. Mol Metab.
Citação norma ChicagoBerti, Lucia, et al. "Fibroblast Growth Factor 21 Is Elevated in Metabolically Unhealthy Obesity and Affects Lipid Deposition, Adipogenesis, and Adipokine Secretion of Human Abdominal Subcutaneous Adipocytes." Mol Metab 2015.
Citação norma MLABerti, Lucia, et al. "Fibroblast Growth Factor 21 Is Elevated in Metabolically Unhealthy Obesity and Affects Lipid Deposition, Adipogenesis, and Adipokine Secretion of Human Abdominal Subcutaneous Adipocytes." Mol Metab 2015.